Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain

Exclusion Criteria

• •Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
• •Planned surgery during the course of the trial
• •Use of prescription drugs for fibromyalgia or nerve pain (e.g.Lyrica, Cymbalta and Savella and others).
• •Use of prescription medications for depression, anxiety or other mental disorders
• •Requires the use of prescription drugs to control pain (other than provided rescue medication)
• •Use of oral or topical prescription or over the counter medications or natural health products for pain relief 3 days prior to randomization and during the trial (other than provided rescue medication)
• •Use of natural health products including vitamins and minerals within 3 days prior to randomization and during the trial
• •Use of blood thinning medications (e.g. warfarin)
• •Chronic lyme disease or chronic parasitic infections
• •Uncontrolled hypertension defined as untreated systolic blood pressure \> 160 mmHg and/or diastolic blood pressure \> 100 mmHg
• •Subjects with diabetes
• •History of bleeding disorders, or significant blood loss in the past 3 months
• •Alcohol use \>2 standard alcoholic drinks per day and/or alcohol or drug abuse within the past year
• •Allergy or sensitivity to study supplement ingredients or acetaminophen
• •Participation in a clinical research trial within 30 days prior to randomization
• •Individuals who are cognitively impaired and/or who are unable to give informed consent
• •Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject